ADIPOQ and Insulin resistance: Since frailty and sarcopenia can lead to insulin resistance in these individuals, insulin resistance could be a key player in the complex relationship among serum adiponectin levels, aging, and CVD, which is referred to as “the adiponectin paradox” (19).